Understanding how to improve eye drop use for glaucoma patients
Quantifying and Understanding Glaucoma Eye Drop Medication Instillation and Adherence
['FUNDING_R01'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11082490
This study is all about helping African American adults with glaucoma use their eye drops more effectively, by understanding the challenges they face and providing personalized support to make sure they get the most benefit from their medication and protect their vision.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11082490 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the way glaucoma patients, particularly African American adults, use their prescribed eye drop medications. It aims to identify the challenges patients face in successfully administering their eye drops, especially considering age-related difficulties. By monitoring medication use and analyzing the biomechanics of eye drop instillation, the study seeks to develop personalized coaching and intervention strategies to enhance adherence and ensure that the medication is effectively delivered. The ultimate goal is to reduce vision loss caused by glaucoma through better medication management.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American adults diagnosed with glaucoma who struggle with adhering to their eye drop medication regimen.
Not a fit: Patients who do not have glaucoma or those who are already successfully managing their medication regimen may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence among glaucoma patients, leading to better management of the disease and reduced risk of blindness.
How similar studies have performed: Previous research has shown that targeted interventions can improve medication adherence in chronic conditions, suggesting that this approach may also be effective for glaucoma patients.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NEWMAN-CASEY, PAULA ANNE — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: NEWMAN-CASEY, PAULA ANNE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.